PrimeRFP SCOUT · Federal Contract Profile

Arcturus Therapeutics (E3MFDBN4L3J9)Federal contracts · 1 recompete

Arcturus Therapeutics holds — in federal volume across 1 award actions. SCOUT tracks 1 incumbent recompete — an estimated $63.2M returning to market over the next 24 months (High exposure). Primary work: Research And Development In (0% prime).

—
Federal Volume
1
Recompetes (24mo)
—
Top Agency
1
Award Actions

Choose one — this changes what we ask next

Score my firm against Arcturus Therapeutics

One email. We send the overlap and watch their recompetes.

Choose one — this changes what we ask next

Data through · refreshed monthly · window Sep 2025 – Sep 2026

Why are you looking at Arcturus Therapeutics?

Score my firm against Arcturus Therapeutics

One email. We send the overlap and watch their recompetes.

What they do

Capability

Service lines

RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

Work mix: 0% prime · 0% sub · primary NAICS 541714 / PSC AN14 HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES

Where they win

0 agencies

No agency activity in window.

Recompete exposure: High · 1 in 24mo

Arcturus Therapeutics has an estimated $63.2M in contracts returning to market over the next 24 months.

Recompete exposure & trajectory

Recompete exposure

High

Arcturus Therapeutics has an estimated $63.2M in contracts returning to market over the next 24 months. 1 within 6 months ($63.2M).

Trajectory
▬ Steady
'24
'25
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
— Gwyne Taylor, Tailored Global
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Arcturus Therapeutics hold?

Arcturus Therapeutics (UEI E3MFDBN4L3J9) shows — across 1 award actions in SCOUT’s public USASpending-backed profile. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Arcturus Therapeutics have?

Arcturus Therapeutics shows — across 1 award actions. SCOUT tracks 1 incumbent recompetes ($63.2M) returning to market in the next 24 months.

Which agencies does Arcturus Therapeutics work with?

Arcturus Therapeutics’s agency mix is assembled from USASpending award records in SCOUT.

What is the UEI for Arcturus Therapeutics?

The Unique Entity ID (UEI) for Arcturus Therapeutics is E3MFDBN4L3J9.

Does Arcturus Therapeutics have contracts coming up for recompete?

Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.

Ten of these with the durability read on each: the FY27 Sprint Pack, $2,800 through Sept 30.

The Pack is ten Pursuit Analyses in a 12-month balance. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

See Tactics on the pricing page

Scout Tactics is $290 a month, with the teaming tools on. It is not sold on this page.

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Sep 10, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/arcturus-therapeutics-inc